Carolina Institute for NanoMedicine (CINM) was established in 2010 as an umbrella program to support multidisciplinary nanotechnology research among investigators from variety of backgrounds including College of Arts & Sciences, UNC Eshelman School of Pharmacy, and UNC School of Medicine. The goal of CINM is to improve human health by enhancing the scientific knowledge as well as the transition of basic research discoveries into clinical trials. CINM harbors two centers: The Carolina Center of Cancer Nanotechnology Excellence (C-CCNE) and The Center for Nanotechnology in Drug Delivery (CNDD)
The center's mission is to pursue an integrated science and engineering program by utilizing emerging carbon nanotechnology to develop new materials, devices and systems. One of their unique strengths is applying advanced synthetic methods to the development of advanced carbon nanomaterials with well-defined, multidimensional structures for multifunctional applications, including electrochemical energy conversion and storage.
The Feng Research Group is working to explore fundamental physics and new engineering of nanoscale solid-state structures and devices. Their research efforts are primarily focused upon emerging nanoscale devices that have strong potential for enabling building blocks and components for novel circuits and transducers, which could lead to future generations of devices and integrated systems for advanced sensing, computing, and communication applications.
The lab's goal is to understand the fundamental design principles of cellular control systems and to apply these principles to engineer cells or cell-like devices with novel, 'smart' therapeutic functions.
The CCNE's goal is goal is to develop and validate nanotechnology so that one will eventually be able to predict which patients will likely respond to a specific anti-cancer therapy and to monitor their response to therapy.
The Center for Cell Control is working to first utilize systems control, with therapeutic intent, to determine the parameters for guiding the cell to a directed phenotype/genotype which will then be followed by in depth study, using nanoscale modalities, of the path by which this desired state is achieved. This approach will enable engineering systems that can be applied towards the regulation of a spectrum of cellular functions, such as cancer eradication, controlling viral infection onset, and stem cell differentiation.
CINT is a Department of Energy/Office of Science Nanoscale Science Research Center (NSRC) operating as a national user facility devoted to establishing the scientific principles that govern the design, performance, and integration of nanoscale materials.
CMPND develops manufacturing protocols and nanostructures for near-term industrial polymeric nanocomposites, emerging polymer photonic components and devices, and more futuristic biomedical devices and systems with nanoscale functions.
CNMM is a joint venture between the University of Maryland and the National Institute of Standards and Technology. Its mission is to advance the science and technology of manufacturing and realization of products based on the use of the unique properties achieved at the nanoscale.
CNER is an Army funded center and exists at four university sites, with the University of Minnesota as the lead institution.Its mission includes developing new methods for nanoparticle growth and surface passivation and developing new Sol-Gel methods for generation of nanostructured materials with emphasis on energy release.
The Center for Nanophase Materials Sciences at Oak Ridge National Laboratory is a collaborative nanoscience user research facility for the synthesis, characterization, theory, modeling, simulation, and design of nanoscale materials. It is one of five Nanoscale Science Research Centers currently being established by the Office of Science, U.S. Department of Energy.